Monday, August 13, 2012: 8:30 AM-11:30 AM
Jefferson East, Concourse Level (Washington Hilton)
Convener:
Tiffany D. Rau
8:30 AM
Technologies to deliver the biopharmaceutical pipeline
Tiffany D. Rau, Rau and Associates, Lake Charles, LA
Tiffany D. Rau, Rau and Associates, Lake Charles, LA
9:00 AM
Injectable polymeric scaffolds with degradable calcium alginate beads as a cell delivery system for tissue repair
Catherine Ward1, Joseph C. Wenke1, Ruijing Guo2 and Scott Guelcher2, (1)US Army Institute of Surgical Research, San Antonio, TX, (2)Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN
Catherine Ward1, Joseph C. Wenke1, Ruijing Guo2 and Scott Guelcher2, (1)US Army Institute of Surgical Research, San Antonio, TX, (2)Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN
10:00 AM
Development of a universal chemically-defined media formulation for cell culture processes
Oscar Lara-Velasco, Christina Waehner and Mary Kate Whitecavage, Biopharmaceutical Development, GlaxoSmithKline, King of Prussia, PA
Oscar Lara-Velasco, Christina Waehner and Mary Kate Whitecavage, Biopharmaceutical Development, GlaxoSmithKline, King of Prussia, PA
10:30 AM
Rapidly delivering the next generation of vaccines and proteins using Pfenex’s expression technology
Torben Bruck1, Tiffany D. Rau2 and Lawrence Chew1, (1)Fermentation Development, Pfenex Inc, San Diego, CA, (2)Rau and Associates, Lake Charles, LA
Torben Bruck1, Tiffany D. Rau2 and Lawrence Chew1, (1)Fermentation Development, Pfenex Inc, San Diego, CA, (2)Rau and Associates, Lake Charles, LA
11:00 AM
Technology improvements to accelerate process development of biologicals
Christopher Kistler, Krista Alvin, Rachel Bareither and David Pollard, Biologics New and Enabling Technologies, Merck & Co., Inc, Rahway, NJ
Christopher Kistler, Krista Alvin, Rachel Bareither and David Pollard, Biologics New and Enabling Technologies, Merck & Co., Inc, Rahway, NJ
See more of: Invited Oral Papers